Anti-Factor VIII antibody [GMA-012]
- BOND RX™ Validated
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Mouse Monoclonal Factor VIII antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 4 publications. Immunogen corresponding to Native Full Length Protein corresponding to Human F8.
View Alternative Names
F8C, F8, Coagulation factor VIII, Antihemophilic factor, Procoagulant component, AHF
- WB
Unknown
Western blot - Anti-Factor VIII antibody [GMA-012] (AB78852)
All lanes:
Western blot - Anti-Factor VIII antibody [GMA-012] (ab78852) at 1 µg/mL
All lanes:
human Factor VIII at 2 µg
Secondary
All lanes:
Goat anti-mouse HRP conjugated IgG
Predicted band size: 267 kDa
Observed band size: 280 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Factor VIII antibody [GMA-012] (AB78852)
IHC image of Factor VIII staining in Human normal liver formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab78852, 5μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Factor VIII greatly contributes to hemostasis by serving as a cofactor for factor IXa forming the intrinsic tenase complex. This activation results in the conversion of factor X to factor Xa which is important for the common pathway of the coagulation cascade. By participating in the clotting process factor VIII ensures proper wound healing and prevention of blood loss.
Pathways
Factor VIII activity is pivotal within the coagulation cascade particularly the intrinsic and common pathways. Activation of the intrinsic pathway begins through interactions with factor IXa leading to efficient activation of factor X. This process closely relates factor VIII to proteins like factor IX and factor X ensuring proper clot formation and stabilization. Factor VIII products and assays are available to study and characterize its critical role in these pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
International journal of oncology 55:1296-1312 PubMed31638182
2019
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 18:3913-3919 PubMed31641378
2019
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 18:1752-1760 PubMed31410134
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neurochemistry 139:757-768 PubMed27565895
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com